TScan Therapeutics
TCRX
TCRX
73 hedge funds and large institutions have $62.9M invested in TScan Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 31
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
73
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$843K | |
| 2 | +$313K | |
| 3 | +$307K | |
| 4 |
Two Sigma Advisers
New York
|
+$135K |
| 5 |
Two Sigma Investments
New York
|
+$99K |
Top Sellers
| 1 | -$709K | |
| 2 | -$544K | |
| 3 | -$334K | |
| 4 |
Millennium Management
New York
|
-$299K |
| 5 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$282K |
